Motivational text messages could be the key to better glycemic control in patients with both diabetes mellitus and coronary heart disease, according to research out of China.

Orchestra BioMed, Inc., on Sept. 4 announced it received CE mark approval for its Moderato implantable pulse generation system, which delivers the company’s trademarked cardiac neuromodulation therapy to patients while simultaneously acting as a pacemaker.

A study out of Emory University has revealed a link between education levels and the odds of developing or dying from CVD, with anything under a graduate degree representing a higher risk of heart disease. 

Research presented at the ESC Congress in Paris Sept. 2 suggests malaria could be linked to as much as a 30% increased risk of heart failure.

Continuous at-home monitoring with smart device-based photoplethysmography technology could be a viable strategy for AFib screening and early detection, according to a population-level study out of China.

Men who live on their own—but not women—struggle to take warfarin as directed, according to research presented Sept. 2 at the ESC Congress in Paris.

Three-year results from the BIO-RESORT trial revealed that despite significant differences in stent backbone and polymer coating, the ultrathin sirolimus-eluting stent, very-thin everolimus-eluting stent and thin-strut zotarolimus-eluting stent remained equally safe and effective through follow-up.

Research presented this month at the ESC Congress in Paris suggests that getting a yearly influenza shot could greatly cut hypertensive patients’ risk of dying during flu season.